@article{5aef401fdae54f67b27b009d91f73eed,
title = "Italian recommendations for the management of pediatric patients under twelve years of age with suspected or manifest Brugada syndrome: Minerva Pediatrica",
keywords = "isoprenaline, quinidine, sodium channel Nav1.5, SCN5A protein, human, adverse event, arrhythmogenesis, Brugada syndrome, electrocardiography, electrophysiology, electrostimulation, fever, gene mutation, genetic screening, heart right bundle branch block, human, lifestyle modification, PR interval, practice guideline, programmed electrical stimulation, QRS interval, QT prolongation, QTc interval, radiofrequency catheter ablation, Review, risk factor, sudden cardiac death, cardiology, child, complication, female, genetics, implantable cardioverter defibrillator, infant, Italy, male, medical society, newborn, pathophysiology, preschool child, sex factor, sport, Brugada Syndrome, Cardiology, Child, Child, Preschool, Death, Sudden, Cardiac, Defibrillators, Implantable, Electrocardiography, Female, Fever, Genetic Testing, Humans, Infant, Infant, Newborn, Male, NAV1.5 Voltage-Gated Sodium Channel, Risk Factors, Sex Factors, Societies, Medical, Sports",
author = "F. Drago and R. Bloise and G. Bronzetti and L. Leoni and G. Porcedda and B. Sarubbi and P. Defilippo and S. Gulletta and M. Scaglione",
note = "Export Date: 11 March 2021 CODEN: MIPEA Correspondence Address: DRAGO, F.; Unit of Pediatric Cardiology and Cardiac Arrhythmias/Syncope, Italy; email: fabrizio.drago@opbg.net Chemicals/CAS: isoprenaline, 299-95-6, 51-30-9, 6700-39-6, 7683-59-2; quinidine, 56-54-2; NAV1.5 Voltage-Gated Sodium Channel; SCN5A protein, human",
year = "2020",
doi = "10.23736/S0026-4946.19.05759-1",
language = "English",
volume = "72",
pages = "1--13",
journal = "Minerva Pediatr.",
issn = "0026-4946",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "1",
}